POP-OUT | CLOSE

An Information Portal to 111749 Biological Macromolecular Structures

Crystal Structure of HIV-1 Neutralizing Antibody CH04
Sequence Clustering and Redundancy Reduction Results
3TCL
Cluster # 4 Members. Sequence cutoff: 90% Cluster size: 433 sequences
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 2VXV 2 L HUMAN IGG ABT-325 9606  
3 4PTU 1 A Antibody pn132p2C05, light chain 9606  
4 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
5 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
6 4NWU 2 L APE1551 Ab Fab light chain 9606  
7 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
8 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
9 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
10 3QRG 1 L Fab light chain 9606  
11 3NCJ 1 L Fab15 Mut8 light chain 9606  
12 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
13 4NWT 1 L APE1531 Ab Fab light chain 9606  
14 3NA9 1 L Fab15 light chain 9606  
15 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
16 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
17 3NAA 1 L Fab15 Mut5 light chain 9606  
18 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606  
19 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
20 3OAZ 2 K, L Fab 2G12, light chain 9606  
21 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
22 4JHA 2 L D25 light chain 9606  
23 4PTT 1 A Antibody pn132p2C05, light chain 9606  
24 4DGV 2 L HCV1 Light Chain 9606  
25 3IU4 2 L chP3 Fab light chain 10090  
26 3P0Y 3 L Fab DL11 light chain 9606  
27 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
28 3NAC 1 L Fab15 Mut7 light chain 9606  
29 4DGY 2 L HCV1 Light Chain 9606  
30 3MXW 2 L 5E1 light chain 9606  
31 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
32 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
33 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
34 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
35 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
36 2FX7 1 L Fab 4E10 Light Chain 9606  
37 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606  
38 3SOB 1 L antibody light chain 9606  
39 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
40 4KQ3 1 L CNTO3186 light chain Fab 9606  
41 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
42 4I77 2 L Lebrikizumab light chain Fab 9606  
43 4HJG 1 A Trastuzumab light chain 9606  
44 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
45 3FN0 1 L Fab Z13e1 light chain 9606  
46 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
47 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
48 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
49 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
50 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
51 3QWO 1 B, L motavizumab light chain 10090  
52 4IOI 1 A Trastuzumab light chain 9606  
53 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
54 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
55 4RBP 1 K, L Fab 2G12 light chain 9606  
56 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606  
57 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
58 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
59 3OAY 1 K, L Fab 2G12, light chain 9606  
60 3TCL 2 B, L CH04 Light Chain Fab 9606  
61 3QOT 1 L B3 (IGKV4-1) light chain 9606  
62 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
63 4X7S 2 L Ig kappa chain C region residues 23-236 9606  
64 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
65 2HFF 1 A, L CB2 Fab, light chain 9606  
66 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
67 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
68 3L5X 1 L H2L6 LIGHT CHAIN 9606  
69 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
70 2R8S 2 L Fab light chain 10090  
71 4HKZ 1 A Trastuzumab light chain 9606  
72 3SO3 2 B A11 FAB light chain 9606  
73 3IDG 1 A 2F5 Fab light chain 9606  
74 3OAU 2 L Fab 2G12, light chain 9606  
75 4WY7 2 L Fab 4E10Light chain 9606  
76 4ZYK 2 B, L AM14 light chain 9606  
77 4HIE 1 A Fab 023.102 9606  
78 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
79 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
80 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
81 4KMT 1 L light chain O12/KAPPA Fab 9606  
82 3NZH 1 L 5F6 LIGHT CHAIN 10090  
83 1RHH 1 A, C Fab X5, light chain 9606  
84 1TJG 1 L FAB 2F5 Light Chain 9606  
85 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
86 4XTR 3 D, F Antibody Light chain 32630  
87 1RZ7 1 L Fab 48d light chain 9606  
88 1RZG 2 B, D Fab 412d heavy chain 9606  
89 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
90 3PGF 3 L SAB Light Chain 9606  
91 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
92 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
93 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
94 2QQN 3 L Antibody light chain 9606  
95 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
96 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
97 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
98 2CMR 3 L D5 9606  
99 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
100 3GRW 2 L Fab light chain 9606  
101 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
102 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
103 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
104 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
105 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
106 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
107 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
108 4HIH 1 A, C Fab 023.102 9606  
109 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606  
110 3DRQ 1 A 2F5 Fab' light chain 9606  
111 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
112 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
113 3D0V 1 A 2F5 Fab heavy chain 9606  
114 3S34 1 L 1121B Fab light chain 10090  
115 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
116 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
117 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
118 2AJ3 1 A, C, E Fab m18, Light Chain 9606  
119 3IDI 1 A 2F5 Fab light chain 9606  
120 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630  
121 4NRX 3 B, E, L m66 Light Chain 9606  
122 3O2D 1 L ibalizumab light chain 10090  
123 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606  
124 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606  
125 2R0L 1 L antibody light chain 32630  
126 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606  
127 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606  
128 3Q1S 1 L Z13e1 Fab light chain 9606  
129 1U8H 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
130 2F5A 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
131 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
132 3KR3 3 L antibody-Fab (light chain) 9606  
133 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
134 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
135 3MOA 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
136 2PR4 1 L nmAb 2F5 Fab' Heavy Chain 9606  
137 4D9Q 2 D, L Anti-Factor D, light chain 9606  
138 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
139 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
140 4QXG 2 L Fab, light chain, IgG1 Fab, light chain 9606  
141 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
142 2FX9 1 L, M Fab 4E10 Light Chain 9606  
143 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090  
144 1TZG 1 L, M Fab 4E10 light chain 9606  
145 3W9D 2 B, D Antibody Fab light chain 9606  
146 1U95 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
147 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606  
148 3BN9 2 C, E E2 Fab Light Chain 9606  
149 4HWE 2 L Fab light chain light chain 9606  
150 1U8K 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
151 3L95 1 A, L anti-NRR1 fab fragment light chain 9606  
152 4OGX 3 L DX-2930 LIGHT CHAIN 9606  
153 3W9E 3 B Antibody Fab light chain 9606  
154 1OM3 1 L, M FAB 2G12, light chain light chain 9606  
155 4KZE 2 L BL3-6 Fab antibody, light chain 10090  
156 4HIJ 1 A, C Fab 023.102 light chain 9606  
157 4XVU 3 D, F, J, L Antibody light chain 32630  
158 3EYF 1 A, C 8f9 Fab 9606  
159 3NAB 1 L Fab15 Mut6 light chain 9606  
160 3IDN 1 A 2F5 Fab light chain 9606  
161 1RZ8 1 A, C Fab 17b light chain 9606  
162 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
163 4FNL 2 L, M Antibody C05, Light Chain 9606  
164 4UB0 2 L IgG1, light chain 9606  
165 1U92 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
166 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
167 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090  
168 1U91 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
169 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606  
170 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090  
171 3IDX 3 L Fab b13 light chain 9606  
172 1U8Q 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
173 3IDJ 1 A 2F5 Fab light chain 9606  
174 3IDM 1 A 2F5 Fab light chain 9606  
175 1U8J 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
176 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
177 4K94 1 L Fab19 heavy chain 9606  
178 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606  
179 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090  
180 3D0L 1 A 2F5 heavy chain 9606  
181 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606  
182 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606  
183 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606  
184 2P8L 1 A nmAb 2F5, light chain 9606  
185 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN FAB FRAGMENT 10090  
186 4XAK 3 E, L Light chain of neutralizing antibody m336 9606  
187 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090  
188 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
189 4NGH 1 L FAB LIGHT CHAIN 9606  
190 4EDW 2 L tanezumab Fab light chain 9606  
191 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
192 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
193 4NM4 1 L, M Antibody CR8043, Light Chain 9606  
194 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606  
195 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606  
196 1U8M 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
197 4D9R 2 D, L Fab light chain 9606  
198 3U7W 2 L Light chain, Ig kappa chain C region 9606  
199 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606  
200 4G7V 2 L fragment antibody light chain 9606  
201 4HFW 1 A, L 6-26 Fab Light chain 9606  
202 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
203 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606  
204 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090  
205 4S1Q 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606  
206 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090  
207 3INU 2 L, N KZ52 antibody fragment light chain 9606  
208 3LEV 2 L 2F5 ANTIBODY LIGHT CHAIN 9606  
209 4OLV 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
210 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606  
211 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
212 4HII 1 A, C Fab 023.102 light chain 9606  
213 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606  
214 4DN3 1 L CNTO888 LIGHT CHAIN 9606  
215 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606  
216 4LSS 3 L LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation 9606  
217 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606  
218 3MOB 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
219 3EYV 1 A, L hu3S193 Fab, light chain 10090  
220 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606  
221 3BDY 2 L Fab Fragment -Light Chain 9606  
222 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606  
223 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
224 3K2U 4 L Antibody, Fab fragment, Light Chain 9606  
225 1U8N 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
226 4HWB 3 L Fab light chain 9606  
227 1U93 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
228 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090  
229 2HFG 1 L CB3s Fab light chain (kappa) 9606  
230 3GKW 2 L Light chain of the antibody Nimotuzumab 9606  
231 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606  
232 4JQI 3 L Fab30 light chain 10090  
233 3SKJ 1 L, M Antibody, light chain 9606  
234 3U30 2 B, E Light chain Fab 9606  
235 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606  
236 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606  
237 2NYY 2 C CR1 monoclonal antibody light chain 9606  
238 2GCY 1 A huC25 fab fragment light chain 10090  
239 4JLR 2 B, L Motavizumab Fab light chain 9606  
240 2QQK 3 L Antibody Light Chain 9606  
241 4J1U 1 A, C, E antibody 93F3 Light chain 10090  
242 2PW2 1 A 2F5 Fab' heavy chain 9606  
243 3NGB 3 C, F, K, L Antigen binding fragment of light chain: Antibody VRC01 9606  
244 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606  
245 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606  
246 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090  
247 2PW1 1 A 2F5 Fab fragment heavy chain 9606  
248 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606  
249 4KXZ 3 I, L, M, P GC1008 Light Chain 9606  
250 1TZH 2 A, L Fab YADS1 Light Chain 10090  
251 4JZJ 3 B, L Fab Light Chain 10090  
252 4M6O 1 L CNTO7309 light chain 9606  
253 4OLW 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
254 4DVR 2 L Fab 48d Light chain 9606  
255 3EYQ 1 C M2J5 Fab 9606  
256 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630  
257 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606  
258 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606  
259 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
260 1U8L 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
261 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
262 3DVG 1 A Human IgG1 fab fragment light chain 9606  
263 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606  
264 2AGJ 1 L Yvo Fab, Light Chain 9606  
265 4JKP 3 L Light chain of antibody 45-46M2 9606  
266 3EYO 1 A, C 8f9 Fab 9606  
267 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606  
268 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606  
269 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606  
270 4DN4 1 L CNTO888 LIGHT CHAIN 9606  
271 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606  
272 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090  
273 2FJG 2 A, L Fab light chain 9606  
274 4DKF 3 L, M FAb2 Light Chain 9606  
275 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090  
276 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606  
277 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090  
278 3EFD 1 L FabL 10090  
279 4LF3 1 A, D Fab heavy chain 10090  
280 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090  
281 4LEO 2 B RG7116 Fab light chain 10090  
282 4G7Y 2 L Fragment antibody light chain 9606  
283 4PY8 4 J antibody 3.1 light chain Fab 9606  
284 3SDY 4 L Antibody CR8020, Light Chain 9606  
285 3DVN 1 A, L Human IgG1 fab fragment light chain 9606  
286 3IXT 1 B, L Motavizumab Fab light chain 10090  
287 2P8M 1 A nmAb 2F5, light chain 9606  
288 4NP4 3 L, M bezlotoxumab light chain 9606  
289 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598  
290 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606  
291 4ERS 1 L Fab light chain 9606  
292 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606  
293 4MWF 2 B, L Fab AR3C light chain 9606  
294 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
295 3SQO 3 L J16 Light chain 9606  
296 4K3J 4 L Onartuzumab Fab light chain 10090  
297 4PS4 1 L M1295 LIGHT CHAIN 9606  
298 3HI1 2 A, L F105 Light Chain 9606  
299 4PY7 2 B, J antibody 3.1 light chain Fab 9606  
300 4K8R 3 C Fab1, light chain 9606  
301 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
302 1ZLU 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
303 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
304 1TZI 1 A Fab YADS2 Light Chain 10090  
305 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606  
306 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090  
307 4X7T 2 B, L Omalizumab-Fab Light chain 9606  
308 4YK4 1 B, Y 641 I-9 VLCL antibody 9606  
309 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606  
310 1MHP 3 L, Y FAB FRAGMENT, light chain 10090  
311 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544  
312 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606  
313 2QQL 3 L Antibody Light Chain 9606  
314 2P8P 1 A nmAb 2F5, light chain 9606  
315 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606  
316 3WD5 2 L Adalimumab Light Chain 9606  
317 4NHC 1 L FAB LIGHT CHAIN 9606  
318 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606  
319 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
320 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606  
321 1ZLW 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
322 4HFU 4 L Fab 8M2 light chain 9606  
323 4FP8 3 L, M, N, O Antibody C05, light chain 9606  
324 4YPG 1 A, L Sifalimumab light chain 9606  
325 3BE1 3 L Fab Fragment-Light Chain 9606  
326 2FJH 2 A, L Fab fragment light chain 9606  
327 4K9E 1 L light chain 10090  
328 3P0V 1 L, M Fab DL11 light chain 9606  
329 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606  
330 1U8O 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
331 4UTA 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 LIGHT CHAIN FAB FRAGMENT 9606  
332 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606  
333 4KVN 3 L Human IgG Light Chain 9606  
334 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606  
335 3OB0 1 K, L Fab 2G12, light chain Fab 9606  
336 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606  
337 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606  
338 4I18 1 B, L antibody light chain Fab 10090  
339 3KYM 1 A, C, E, G, I, K, M, O Light Chain Li33 IgG2 9606  
340 3IDY 3 C, L Fab b13 light chain 9606  
341 4OQT 2 L Light Chain of Li81 Fab, kappa 3 9606  
342 3IVK 1 B, L Fab light chain man 10090  
343 3KYK 2 L Light Chain Li33 IgG1 9606  
344 4IRZ 2 L Fab Natalizumab light chain 9606  
345 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606  
346 2R56 2 L, M IgE Fab Fragment, light chain 9606  
347 1ZA6 1 A, C, E, G IGG Light chain 9606  
348 4ZS6 1 D, L fab Light Chain 9606  
349 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606  
350 1U6A 1 L F105 LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
351 1NGW 1 A, L Mature Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
352 4P59 3 L MOR09825 Fab fragment light chain 9606  
353 4LMQ 3 I, L Stromal cell-derived factor 1 9606  
354 3N85 2 L Fab37 Light Chain 9606  
355 3G6J 3 E, G Fab light chain 9606  
356 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606  
357 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606  
358 4DKE 3 L, M FAb1.1 Light Chain 9606  
359 3DRT 1 A 2F5 Fab' light chain 9606  
360 1U8P 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
361 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606  
362 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606  
363 4R8W 4 L Light chain of neutralizing antibody CT149 9606  
364 1I9R 3 L, M, Y IMMUNOGLOBULIN L 9606  
365 4NRY 1 B, L m66 Heavy Chain 9606  
366 3S37 1 L 1121B Fab light chain 10090  
367 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090  
368 4JM2 3 C 17b Light chain Fab 9606  
369 1S78 2 C, E Pertuzumab Fab light chain 10090  
370 1OP5 1 K, L FAB 2G12, light chain light chain 9606  
371 4NYL 1 B, D, F, L Adalimumab Light Chain 9606  
372 4XHJ 3 C, G Fab-RC light chain 9606  
373 4JDT 3 L Fab light chain NIH45-46 LIGHT CHAIN 9606  
374 4N90 3 E, G, I Fab light chain 9606  
375 4UBD 4 D, H, L, P, T, X monoclonal antibody L chain 9606  
376 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606  
377 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598  
378 3EO1 1 A, D, G, J GC-1008 Fab Light Chain 10090  
379 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090  
380 4IOF 3 D, F Fab-bound IDE, light chain 10090  
381 4JHW 2 L D25 light chain 9606  
382 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606  
383 3BQU 1 A 2F5 Fab' light chain 9606  
384 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606  
385 4M1C 3 D, F Fab-bound IDE, light chain 9606  
386 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606  
387 3ULV 2 L Fab15 light chain 9606  
388 4M7L 2 L 10H10 light chain SEE REMARK 999 10090  
389 4S1R 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606  
390 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606  
391 3EGS 1 A 2F5 Fab' light chain 9606  
392 2NZ9 2 C, E AR2 monoclonal antibody light chain 9606  
393 3S36 1 L 1121B light chain 10090  
394 3DRO 1 A 2F5 Fab light chain 9606  
395 4S1S 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606  
396 2R0K 2 L antibody light chain of Fab58 9606  
397 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606  
398 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606  
399 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606  
400 4G80 3 B, D, F, H fragment antibody light chain 9606  
401 3X2D 3 C, G, K, O Fab light chain 9606  
402 3JWO 3 L FAB 48D LIGHT CHAIN 9606  
403 3P11 2 L Fab DL11 light chain 9606  
404 3F12 1 A, C M2J1 Fab 9606  
405 3B2V 1 L IMC-11F8 FAB Light chain 9606  
406 3ULU 2 L Fab15 light chain 9606  
407 4XI5 3 C Fab-94 light chain 9606  
408 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606  
409 4Q5Z 3 J, L, N, P, R, T, V, X IDE-bound Fab, light chain 10090  
410 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606  
411 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606  
412 2B4C 3 L anti-HIV-1 gp120 immunoglobulin X5 light chain 9606  
413 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606  
414 3EFF 1 A, C FAB 10090  
415 3PJS 1 A, C FAB light chain 10090  
416 4ZYP 3 L, M, O Motavizumab antibody light chain 10090  
417 4ZYP 5 E, G, I AM14 antibody light chain 9606  
418 4RQS 2 C 17b Fab Light Chain 9606  
419 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606  
420 4R4H 3 L Antibody 2.2c, Light chain 9606  
421 4XMN 6 L Antibody 87 light chain 32630  
422 4XMM 8 L Antibody 57 light chain 9606  
423 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606  
424 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606  
425 5A8H 3 C, I, O FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606  
426 5A7X 3 C, G, K FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606  
427 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606  
428 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606  
429 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606  
430 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606  
431 2ESG 1 L, M Immunoglobulin A1 light chain 9606  
432 1R70 1 A, C Human IgA2(m1) Light Chain 9606  
433 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606  
 
Sequence Clusters for the Sequence Entities in PDB 3TCL
Entity #1: Chains: A,H - CH04 Heavy Chain Fab protein, length: 237 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 3 12198
95% 1 3 11602
90% 1 3 11424
70% 280 1682 1
50% 571 3477 1
40% 571 3478 1
30% 620 4103 1
Entity #2: Chains: B,L - CH04 Light Chain Fab protein, length: 215 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 1 33157
95% 1 1 25415
90% 60 433 4
70% 233 1454 3
50% 572 3477 1
40% 572 3478 1
30% 621 4103 1
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.